UNSPSC 51422427: Hydrocortisone butyrate propionate

This classification denotes an anti-inflammatory agent with the molecular formula C28H40O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O6550D6K3A, chemically known as 11.beta.-hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregn-4-ene-3,20-dione, but more generally known as hydrocortisone butyrate propionate, which bears US NIH Compound Identifier 51627. European Medicines Agency schedules hydrocortisone butyrate propionate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08065MIG.

Most nations, for tariff purposes, schedule hydrocortisone butyrate propionate under HS 29372100. SMILES: CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)COC(=O)CC.

UNSPSC 51422427 Hydrocortisone butyrate propionate is a Commodity code with a significant mismatch between its nominal pharmaceutical scope and the recent state and local activity it is capturing. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS posted June 30, 2026 — solicits Naloxone and Safe Drug Deactivation Systems, neither of which is hydrocortisone butyrate propionate or a related corticosteroid. Naloxone is an opioid antagonist used for overdose reversal, and drug deactivation systems are containment or destruction equipment; neither product falls within the code's pharmaceutical steroid classification. The mismatch suggests either a cataloging error in the state and local system or a broad misapplication of the code to unrelated pharmaceutical and medical-supply procurements.

Seminole County's procurement is seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year contract term and a one-year renewal option. The IFB required electronic bid submission through the county's e-Procurement Portal with a response deadline of July 26, 2023, and mandates E-Verify compliance, workers' compensation insurance, and commercial general liability coverage. The contract was potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The code shows minimal recent activity—this single, non-representative opportunity does not signal meaningful procurement volume or buyer concentration for hydrocortisone butyrate propionate or related corticosteroids under this Commodity classification. Firms pursuing steroid or topical pharmaceutical contracts should verify code assignment in RFP, RFQ, and IFB notices before bidding, as the current tagging appears unreliable.